DIANT Pharma was founded in 2019 and has developed a continuous processing technology for nanoparticle drug products. We are dedicated to bringing the highest quality products to patients with a technology that is robust and reliable over a product’s lifespan.
Our proprietary continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space.
We are always looking for partners to broaden the use of our technology.
Antonio Costa, Ph.D.
Founder/Chief Executive Officer
He has extensive knowledge on processing of nanoparticles with 7 years working on the development of the UConn continuous manufacturing system.
Diane Burgess, Ph.D.
As a distinguished professor in pharmaceutics at UConn, she has 30+ years experience in a variety pharmaceutical formulations and a subject matter expert in drug product dissolution testing.
Chief Commercial Officer
He was the executive Vice President & Chief Commercial Officer at Avara Pharmaceutical Services and has extensive commercial experience, including Executive Vice President and CCO, Director of Sales, Area Sales Director and Regional Sales Director experience leading sales and marketing teams.
Head of Engineering
President of Bozenhardt Consulting Services LLC. He has 43 years of experience in pharmaceutical, biotech and medical device manufacturing, engineering and compliance.
He is the founder of Bioprocess Resources LLC and CEO of G-CON Manufacturing Inc. He is a biopharmaceutical business veteran with over 30 years experience and subject matter expertise in filtration, separation, single-use processes and flexible facility technologies, embracing the related regulations and validation requirements.
Makarand Jawadekar, Ph.D.
He worked at Pfizer Inc. for 28 consecutive years in roles such as Director, Portfolio Management. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies.
He was director, competitive intelligence at Novartis Pharma AG has 20+ years of experience in pharmaceutical strategy, marketing and clinical development.